Global extracorporeal membrane oxygenation (ECMO) Machine Market: Snapshot
The development of extracorporeal membrane oxygenation (ECMO) therapies occupies a significant role in a fast expanding armamentarium of organ support measures available with clinicians from multidisciplinary teams. The new approach is gaining traction in the intensive care management of acute cardiac and respiratory failures among adult patients in various developing and developed regions. ECMO machines are witnessing wide demand for managing various types of acute respiratory distress syndrome (ARDS) or for patients recovering from heart or lung failures. In recent years, the growing number of indications for the use of ECMO technique in severe cardiac or pulmonary failures is attributed to their better efficacy than most conventional therapies or modes of treatment used by clinicians. Recent advancements in standardized ECMO clinical practices, notably in venovenous ECMO, are expected to open up promising avenues in the extracorporeal membrane oxygenation market. ECMO machines are gaining traction as a bridge for patients awaiting heart or lung transplant.
The global extracorporeal membrane oxygenation machine market is projected to rise from a worth of US$266.3 Mn in 2017 to reach a valuation of US$376.0 Mn by 2022 end. The market is estimated to rise at a CAGR of 7.1% during the forecast period of 2017–2022.
Venovenous ECMO Anticipated to be Emerge as Dominant Modality
The major modalities used in ECMO machine are venovenous, venoarterial, and arteriovenous. Among these, the venovenous ECMO segment currently holds the leading share estimated to be 47.7% in 2017 and is expected to maintain its dominance during 2017–2022. The segment that is worth US$126.9 Mn is projected to reach US$177.3 Mn in by the end of the forecast period. This represents a share of 47.1% in the overall ECMO modality market. The segment is projected to rise at a CAGR of 6.9% during the same period. The annual growth of the segment is pegged at US$10.1 Mn annually during the assessment period, representing an absolute growth which is higher than all other modality segments. The wide popularity of venovenous ECMO modalities in managing acute cardiac or pulmonary failures is on the account of their capability for complete respiratory support and is mainly attributed to their improved clinical outcomes.
North America to Present Vast Lucrative Avenues over Assessment Period
The various regional markets for global extracorporeal membrane oxygenation machine comprise North America, the Middle East and Africa, Latin America, Asia Pacific excluding Japan (APEJ), Japan, and Europe. Of these, North America is projected to hold the leading shares, vis-à-vis revenue, of the global market throughout the forecast period. The regional market is projected to rise from US$90.1 Mn in 2017 to reach US$128.2 Mn by the end of 2022. This accounts for CAGR of 7.3% from 2017 to 2022. The prominence of the regional market is attributed mainly to favorable reimbursement scenario in several nations and the rising demand for various ECMO modalities in the management of patients with lung cancer and ARDS.
APEJ to Rise at Impressive Pace
APEJ is a prominent regional market for extracorporeal membrane oxygenation machine as it accounts for a revenue share of 22.0% of the global market by the end of 2017. The regional market is projected to gain a market share estimated at 76 BPS between 2017 and 2022. The rising prevalence of cardiovascular disease (CVD) in various parts of the region is expected to fuel the demand for ECMO machines
Key players operating in the extracorporeal membrane oxygenation machine market include Medtronic Plc., Getinge AB, Terumo Corporation, LivaNova PLC, MicroPort Scientific Corporation, Xenios AG, Nipro Corporation, Eurosets S.r.l., and ALung Technologies, Inc. A number of the leading players opt for innovative product launches and are adopting partnerships and collaborations as key strategies to gain a competitive edge over others.
Global Extracorporeal Membrane Oxygenation Machine Market: Overview
The report on the global extracorporeal membrane oxygenation machine (ECMO) market offers a detailed evaluation of various trends and factors impacting the growth of the market over the period of 2017–2022. The research provides in-depth insight into notable clinical developments, technological advances, offerings of key market players, and competitive landscape. The study offers a granular analysis of supply chain and cost structure, prominent pricing strategies, and key factors demand among major regional markets. The study presents a critical insights into the epidemiology of the indications for the use of extracorporeal membrane oxygenation therapies. Furthermore, it provides an evidence-based assessment of regulatory framework impacting the market dynamics in various regions during the assessment period. The market projections during the forecast period helps stakeholders identify current and emerging opportunities, which will enable them to leverage on emerging opportunities in the foreseeable future.
The global extracorporeal membrane oxygenation machine market is estimated to be worth US$266.3 Mn by 2017 end and is projected to reach a valuation of US$376.0 Mn by 2022 end. The market is forecast to rise at a CAGR of 7.1% during the forecast period (2017–2022).
Global Extracorporeal Membrane Oxygenation Machine Market: Dynamics
The report offers a detailed assessment of key drivers and restraints, regulatory landscape and strategic dynamics prevailing in various regions, and the share and size of various segments. The study offers a comparative analysis by capturing the year-over-year (YoY) growth of various application and modality segments during the historical period (2012–2016) across various regions. The insights are helpful in identifying prominent trends and promising opportunities shaping the growth dynamics of the market.
The extracorporeal membrane oxygenation machine is primarily driven by its rising demand for ECMO therapies for the management of various types of severe cardiac and respiratory failures among adults and children. The growing acceptance of ECMO in managing specific types of acute respiratory distress syndrome (ARDS) is a key factor accentuating the market. The demand for ECMO therapies for providing extracorporeal life support for patients recovering from heart failure or lung failure that do respond to conventional life support modalities such as ventilation bodes well for the market. The growing acceptance of ECMO machines to provide prolonged support for respiratory and cardiac functions in adult patients is opening up exciting opportunities for market players. Furthermore, the soaring popularity of extracorporeal cardiopulmonary resuscitation (ECPR), attributed to its significant survival benefits, in rescuing patients with specific cardiac arrest that does not respond to conventional resuscitation, is expected to open up lucrative avenues during the forecast period.
Global Extracorporeal Membrane Oxygenation Machine Market: Segmentation
The report segments the overall extracorporeal membrane oxygenation machine market on the basis of modality, application, and region.
Based on modality, the report segments the global market broadly into venovenous ECMO, venoarterial ECMO, and arteriovenous ECMO. Of these, the venovenous ECMO segment currently holds the leading share and is anticipated to maintain its lead in the next few years as well.
On the basis of application, the report divides the market into respiratory, cardiology, and extracorporeal cardiopulmonary resuscitation.
The regional markets discussed in the study are Latin America, North America, the Middle East and Africa (MEA), Europe, Asia Pacific excluding Japan (APEJ), and Japan. Of these, the North America extracorporeal membrane oxygenation machine market is anticipated to be the most attractive and is expected to maintain a dominant revenue share throughout the forecast period.
Companies profiled in the report are:
The report offers an elaborate profiling of prominent market players, analyzes factors affecting their revenue share, and highlights key strategies adopted by various companies to gain a better foothold in the market. The market participants can get a critical insight into the strategic landscape and gauge the intensity of the competition during the forecast period. Some of the prominent players profiled in the report are Medtronic Plc., Getinge AB, Terumo Corporation, LivaNova PLC, MicroPort Scientific Corporation, Xenios AG, Nipro Corporation, Eurosets S.r.l., and ALung Technologies, Inc.